Results 211 to 220 of about 37,267 (288)

Dreaming of Better Treatments: Advances in Drug Development for Sleep Medicine and Chronotherapy

Journal of Sleep Research, EarlyView.
ABSTRACT Throughout history, the development of new sleep medicines has been driven by progress in our understanding of the mechanisms underlying sleep. Ancient civilisations used their understanding of the sedative nature of natural herbs and compounds to induce sleep.
Brooke A. Prakash, Ishani Shah, Guohao Ni, Sridhar Vasudevan, Aarti Jagannath, Russell G. Foster   +5 more
wiley   +1 more source

Immune Therapies in AL Amyloidosis-A Glimpse to the Future. [PDF]

Cancers (Basel)
Haran A, Vaxman I, Gatt ME, Lebel E.
europepmc   +1 more source

A CASE OF (AL) AMYLOIDOSIS THAT OCCURRED MULTIPLE INTESTINAL PERFORATION DURING PACLITAXEL CHEMOTHERAPY

, 2010
Tsuyoshi Fukushima, Hidekazu Sano, Kazutomo KIKUCHI, Masataka Wada, Yumi Okawa, Keisa Takeda   +5 more
openalex   +2 more sources

Enteric neuropathy and the vagus nerve: Therapeutic implications

Neurogastroenterology &Motility, EarlyView.
Abstract Enteric neuropathies are characterized by abnormalities of gut innervation, which includes the enteric nervous system, inducing severe gut dysmotility among other dysfunctions. Most of the gastrointestinal tract is innervated by the vagus nerve, the efferent branches of which have close interconnections with the enteric nervous system and ...
Bruno Bonaz
wiley   +1 more source

SGLT‐2 inhibitors for cardiac amyloidosis: Hype or hope?

European Journal of Clinical Investigation, EarlyView.
Flavio Tangianu, Eleonora Nicolini, Francesco Dentali, Aldo Bonaventura   +3 more
wiley   +1 more source

Studying the Role of Myenteric Amyloidosis in Gastrointestinal Dysmotility and Enteric Neural Dysfunction Using APP/PS1 Mice—Is It an Adequate Animal Model?

Neurogastroenterology &Motility, EarlyView.
Amyloidosis in the central and enteric nervous system contributes to cognitive deficits and gastrointestinal dysmotility—the constipation in Alzheimer's disease (AD). APP/PS1 mice, a transgenic mouse model of amyloidosis, recapitulated the amyloidosis in the central nervous system; they were unsustainable in recapitulating the amyloidosis in the ...
Roxanne Fernandes, Marlene Masino, Emma Flood, Theresa A. Lansdell, Nikitha Srikrishna, Ryan Mui, Anne M. Dorrance, James J. Galligan, Hui Xu   +8 more
wiley   +1 more source

Erratum to "The First Case of Familial Mediterranean Fever Associated with Renal Amyloidosis in Korea" by Koo KY, et al. (Yonsei Med J 2012;53:454-8.)

, 2012

openalex   +2 more sources

Febrile neutropenia in patients with Duffy-null-associated neutrophil counts and multiple myeloma or AL amyloidosis. [PDF]

Blood Adv
Abdallah M, Arters F, Patel J, Edwards C, Lerner A, Petrocca F, Dockerty M, Fuller B, Godfrey A, Staron A, Sanchorawala V, Sloan JM, Bertrand K, Szalat R.   +13 more
europepmc   +1 more source

Bortezomib and high-dose melphalan conditioning for stem cell transplantation for AL amyloidosis: a pilot study

, 2011
Vaishali Sanchorawala, Karen Quillen, J. Mark Sloan, Nancy Andrea, David C. Seldin   +4 more
openalex   +2 more sources

The conundrum of esophagogastric junction outflow obstruction: Answers to key clinical questions

Annals of the New York Academy of Sciences, EarlyView.
Esophagogastric junction outflow obstruction (EGJOO) is a heterogeneous disorder characterized by abnormal esophagogastric junction pressures in the setting of intact peristalsis. The significance of this finding is highest in patients with dysphagia or chest pain, and in patients for whom there is a clinical suspicion for an achalasia variant.
Kristle Lee Lynch, C. Prakash Gyawali, Enrique Coss‐Adame, Stefano Siboni, Christopher Vélez, Abraham Khan, Pierfrancesco Visaggi, Joshua A. Sloan, Sravanya Gavini, Marco Sozzi, Justin Wu   +10 more
wiley   +1 more source